EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Association between Prolactinoma and Incident Type 2 Diabetes Mellitus: Evidence from a Korean Nationwide Cohort

Han Na Jung, Bo Ram Yang, Min-Seon Kim, Jeong-Hwa Yoon, Se Hee Min

Endocrinology and Metabolism · 30.06.2026 · 41 (3) · 452-460

DOI: 10.3803/enm.2025.2508 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Endocrinology and Metabolism, erschienen am 30.06.2026. Verfasst von Han Na Jung und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Endocrinology and Metabolism, Department of Internal Medicine, Hallym University Sacred Heart Hospital, Anyang, Korea. Hauptthemen laut MEDLINE: Prolactinoma, Diabetes Mellitus, Type 2, Pituitary Neoplasms. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Research Foundation of Korea, Ministry of Education, Ministry of Science and ICT.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The effect of prolactinoma on the development of type 2 diabetes mellitus (T2DM) has not been evaluated at the population level. We investigated the association between prolactinoma and incident T2DM in a nationwide cohort.

Methods

We analyzed data from the Korean National Health Insurance Service–National Sample Cohort, which includes 2% of the total national population selected by random sampling, covering the period from 2002 to 2019. A total of 335 patients with newly diagnosed prolactinoma and 1,562 age- and sex-matched controls were included. We calculated hazard ratios (HRs) and 95% confidence intervals (CIs) for T2DM using Cox proportional hazards regression. Time-dependent HRs were also estimated.

Results

The proportion of prolactinoma patients who developed T2DM was significantly higher than that of controls (10.1% vs. 5.5%; relative risk, 1.84; 95% CI, 1.26 to 2.69). After adjustment for age, sex, income, and comorbidities, the risk of T2DM remained significantly higher in the prolactinoma group (HR, 1.56; 95% CI, 1.01 to 2.41). Subgroup analysis showed a markedly increased risk among individuals aged ≥50 years (HR, 4.47; 95% CI, 1.66 to 12.08). The positive association between prolactinoma and T2DM decreased over time but remained significant for up to 3 years after prolactinoma diagnosis (HR, 9.28 [95% CI, 3.45 to 24.97]; HR, 3.15 [95% CI, 1.55 to 6.38]; and HR, 0.82 [95% CI, 0.44 to 1.53] for ≤1, 1–3, and >3 years, respectively).

Conclusion

Newly diagnosed prolactinoma was independently associated with a higher risk of T2DM, with the association diminishing over 3 years. These findings highlight the importance of monitoring for T2DM during the early management of prolactinoma, particularly in middle-aged patients who may have been previously overlooked.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ProlactinomaDiabetes Mellitus, Type 2Pituitary NeoplasmsHumansFemaleMiddle AgedRepublic of KoreaMaleAdultIncidenceRisk FactorsCase-Control StudiesAgedFollow-Up StudiesCohort Studies

Stichwörter der Autor:innen

Diabetes mellitus, type 2HyperprolactinemiaInsulin resistanceProlactinoma

Autor:innen und Institutionen

  • Division of Endocrinology and Metabolism, Department of Internal Medicine, Hallym University Sacred Heart Hospital, Anyang, Korea.
  • Department of Internal Medicine, University of Ulsan College of Medicine, Seoul, Korea.
  • College of Pharmacy, Chungnam National University, Daejeon, Korea.
  • Department of Bio-AI Convergence, Chungnam National University, Daejeon, Korea.
  • Division of Endocrinology and Metabolism, Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
  • Medical Big Data Research Center, Medical Research Center, Seoul National University, Seoul, Korea. yjh891114@snu.ac.kr.

Förderung

  • National Research Foundation of Korea
  • Ministry of Education
  • Ministry of Science and ICT
  • Asan Institute for Life Sciences, Asan Medical Center

Zitieren

APA

Jung, H. N., Yang, B. R., Kim, M. S., Yoon, J. H., & Min, S. H. (2026). Association between Prolactinoma and Incident Type 2 Diabetes Mellitus: Evidence from a Korean Nationwide Cohort. Endocrinology and Metabolism, 41(3), 452-460. https://doi.org/10.3803/enm.2025.2508

Vancouver

Jung HN, Yang BR, Kim MS, Yoon JH, Min SH. Association between Prolactinoma and Incident Type 2 Diabetes Mellitus: Evidence from a Korean Nationwide Cohort. Endocrinology and Metabolism. 2026;41(3):452-460. doi:10.3803/enm.2025.2508

BibTeX
@article{Jung2026,
  author = {Jung, Han Na and Yang, Bo Ram and Kim, Min-Seon and Yoon, Jeong-Hwa and Min, Se Hee},
  title = {Association between Prolactinoma and Incident Type 2 Diabetes Mellitus: Evidence from a Korean Nationwide Cohort},
  journal = {Endocrinology and Metabolism},
  year = {2026},
  volume = {41},
  number = {3},
  pages = {452--460},
  doi = {10.3803/enm.2025.2508}
}
Kostenlos starten →